A new study has revealed that use of a twice-daily pill could turn a deadly blood cancer into a highly treatable disease suggesting that people suffering from chronic lymphocytic leukemia (CLL) may be able to avoid having to take debilitating chemotherapy. According to scientists at Weill Cornell Medical College who led a multinational research team the treatment today for CLL can be worse than the disease leading to a great deal of side effects and death. 'This study and others we have conducted on idelalisib demonstrates that we may no longer need to use chemotherapy in CLL. Even if this
